Cargando…
Lorcaserin Inhibit Glucose-Stimulated Insulin Secretion and Calcium Influx in Murine Pancreatic Islets
Lorcaserin is a serotonergic agonist specific to the 5-hydroxytryptamine 2c receptor (5-HT(2C)R) that is FDA approved for the long-term management of obesity with or without at least one weight-related comorbidity. Lorcaserin can restrain patients’ appetite and improve insulin sensitivity and hyperi...
Autores principales: | Jing, Muhan, Wang, Shanshan, Li, Ding, Wang, Zeyu, Li, Ziwen, Lu, Yichen, Sun, Tong, Qiu, Chen, Chen, Fang, Yu, Haijuan, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602196/ https://www.ncbi.nlm.nih.gov/pubmed/34803706 http://dx.doi.org/10.3389/fphar.2021.761966 |
Ejemplares similares
-
Lorcaserin for weight management
por: Taylor, James R, et al.
Publicado: (2013) -
GRK2 contributes to glucose mediated calcium responses and insulin secretion in pancreatic islet cells
por: Snyder, Jonathan, et al.
Publicado: (2021) -
Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets
por: Dai, C., et al.
Publicado: (2011) -
ADCY5 Couples Glucose to Insulin Secretion in Human Islets
por: Hodson, David J., et al.
Publicado: (2014) -
Lorcaserin: A novel antiobesity drug
por: Brashier, Dick B. S., et al.
Publicado: (2014)